Ambu Donates Lifesaving Resuscitators to International Medical Corps as Part of the Ambu® BagTM’s 65th Birthday Celebration

2022-09-10 03:14:15 By : Mr. Howard Wang

International Medical Corps is using Ambu Bags to save lives in Ukraine and across Africa.

COLUMBIA, Md., September 07, 2022--(BUSINESS WIRE)--Ambu Inc., the world leader in single-use endoscopy, celebrated the 65th birthday of its iconic invention, the Ambu® BagTM, today by donating 650 of the lifesaving devices to International Medical Corps, a global humanitarian organization.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220907005336/en/

Allan Jensen, Vice President of Sales, Anesthesia at Ambu, presented the Ambu Bags to Rebecca Milner, Chief Advancement Officer at International Medical Corps, in a ceremony at Ambu’s U.S. headquarters in Columbia, MD. International Medical Corps will use the Ambu Bags to save lives in Ukraine and across Africa, including the Central African Republic, South Sudan, Cameroon, and Somalia.

"We are so grateful to Ambu for its generous donation of Ambu Bags," Milner said. "The donation of critical medical equipment like the Ambu Bag enables our organization to provide more lifesaving services to people in need, whether they’re affected by rapid-onset disasters or suffering from the long-term effects of conflict or disease."

Established in 1984 by volunteer doctors and nurses, International Medical Corps is dedicated to improving quality of life through health interventions, training and related activities that strengthen underserved communities worldwide.

The Ambu Bag is the ubiquitous lifesaving medical device that has helped more than 45 million people breathe in the last 10 years alone. It has come to define the self-inflating manual resuscitation instrument that is part of any standard kit carried by first responders. Called a "quintessential piece of equipment," the Ambu Bag is found in ambulances and throughout hospitals, including the ER to the OR.

"Ambu greatly appreciates the vital work of the more than 7,500 International Medical Corps staff around the world working to save lives and relieve suffering," Jensen said. "I can’t think of a better way to commemorate the history of the Ambu Bag than to give back to the doctors, nurses, and first responders who rely on this device to save patients’ lives every day."

ABOUT AMBU Ambu has brought solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anesthesia and patient monitoring solutions. We continuously look ahead with a commitment to deliver innovative quality products that have a positive impact on patient care and the work of healthcare professionals. Headquartered near Copenhagen in Denmark, Ambu employs approximately 5,000 people in Europe, North America and Asia-Pacific. For more information, please visit Ambu.com or AmbuUSA.com or follow us on our Corporate LinkedIn and USA LinkedIn pages.

ABOUT International Medical Corps International Medical Corps is a global first responder that delivers emergency medical and related services to those affected by conflict, disaster and disease, no matter where they are, no matter the conditions. It also trains people in their communities, providing them with the skills they need to recover, chart their own path to self-reliance and become effective first responders themselves. Established in 1984 by volunteer doctors and nurses, it is a nonprofit with no religious or political affiliation, and now has roughly 7,500 staff members around the world, 97% of whom are locally hired. Since its founding, it has operated in more than 80 countries, and provided more than $3.9 billion in emergency relief and training to communities worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005336/en/

North America media Jens Kemp, Vice President, Marketing, jke@ambu.com +1 410 303 9722 Ambu Inc., 6721 Columbia Gateway Drive, Columbia, Maryland, 21045, United States, www.ambuusa.com/. European media Tine Bjørn Schmidt, Head of Corporate Communications, tisc@ambu.com, +45 2264 0697 Ambu A/S, Baltorpbakken 13, 2750 Ballerup, Denmark, Tel. +45 7225 2000, CVR no.: 63 64 49 19, www.ambu.com/.

Nursing homes and debt collectors are billing and suing long-term-care residents’ family members and friends, demanding payments for debts these individuals don’t legally owe, consumer attorneys and federal regulators are claiming. Under federal law, nursing homes participating in Medicare and Medicaid can’t make such provisions a condition of admission or continued stay in the facility.

The FDA is convening an adcomm meeting of its Pulmonary-Allergy Drugs Advisory Committee, slated for October 6, to discuss Veru Inc's (NASDAQ: VERU) request for Emergency Use Authorization of sabizabulin for hospitalized COVID-19 patients at high risk for ARDS. In a public notice, the FDA said that as part of the adcomm, one of the focuses of the experts will include "the treatment effect size in the context of the high placebo mortality rate, the limited size of the safety database, and identif

Regeneron's Eylea eye-disorder drug faces competitive pressure on multiple fronts. New data could cement its dominance.

When planning for the future, health care ranks as one of the highest concerns for both savers and retirees alike. Not only are health care costs rising by more than 5% every year, but rampant inflation and volatile market performances … Continue reading → The post New Bill May Allow Penalty-Free 401(k) Withdrawals for This Retirement Expense appeared first on SmartAsset Blog.

These strategies can help you reduce your health care costs.

Shares of Shuttle Pharmaceuticals Holdings (NASDAQ: SHPH) climbed 160.4% this week, according to data from S&P Global Intelligence. The stock closed at $14.90 last Friday and then opened this Tuesday at $12.16. The stock began trading on Aug. 31 after its initial public offering (IPO).

The FDA's PCNSDAC recommends granting marketing approval to Amylyx's (AMLX) oral drug, which slows the progression of ALS.

Cara Therapeutics Inc (NASDAQ: CARA) announced results from the KOMFORT Phase 2 clinical trial of oral difelikefalin for moderate-to-severe pruritus in notalgia paresthetica (NP). Notalgia paresthetica (NP) is a nerve disorder that causes intense and sometimes painful itching in the back impacting quality of life. The data will be presented at the European Academy of Dermatology and Venereology (EADV) Congress. The presentation includes data from 125 patients with NP and moderate-to-severe pruri

ALBANY, N.Y. — New York declared a state of emergency on Friday to boost vaccinations against polio. Gov. Kathy Hochul issued an executive order expanding the state’s network of vaccine administrators to EMS workers, midwives and pharmacists as evidence mounts that the once rare virus is spreading in the state. Only one case of paralytic polio has been recorded in Rockland County so far, but ...

Amylyx Pharmaceuticals Inc. shares were riding high in the first few hours of trading following a key FDA advisory committee's positive vote on its first drug, despite the unusual caveats that accompanied the vote.

Studies "support aflibercept 8 mg as a potential new standard-of-care," Regeneron Pharmaceuticals said. Regeneron stock leapt in huge volume.

Parkinson's disease (PD) may be an issue that stems from the health and function of your brain, according to the National Institute on Aging. However, a new study recently published by JAMA Network Open also reveals a connection between eating habits and mortality rates for those with PD.In a study titled "Association of Diet and Physical Activity With All-Cause Mortality Among Adults With Parkinson Disease," researchers took a look at 1,251 participants who were previously diagnosed with Parkin

(Bloomberg) -- Former White House strategist Steve Bannon vowed to fight a New York state case accusing him of defrauding thousands of contributors to a privately funded US-Mexico border wall of more than $15 million.Most Read from BloombergCharles Becomes King as the Face of a Nation ChangesDouble Rainbow Appears Over Buckingham Palace as Crowd Gathers to Mourn QueenUkraine Army’s Breakthrough in North Threatens Russian GripQueen Elizabeth’s Doctors Are Concerned for Her HealthQueen Elizabeth I

Amgen's biosimilar drug is close to stealing away sales from AstraZeneca's rare disease drug called Soliris.

A Pennsylvania woman is claiming that she spent four days in the hospital after biting into a scrap of metal in her chicken fries order from Burger King.

It seems like every major technology company wants to disrupt healthcare. It's easy to see why as the United States spends nearly 18% of its gross domestic product (GDP) on healthcare. "...Because national health expenditures are projected to grow 1.1 percentage points faster than gross domestic product per year on average over 2019-28, the health share of the economy is projected to rise from 17.7% in 2018 to 19.7% in 2028."

Two deputies died in an ambush while attempting to serve a warrant at a home near Atlanta, a sheriff said Friday. A standoff with more law enforcement officers ensued afterwards.

CLAIM: A federal court order in the legal dispute over government documents held by former President Donald Trump shows President Joe Biden ordered the FBI search at Trump’s Florida home. THE FACTS: While Monday's court order from U.S. District Judge Aileen Cannon does include the phrase “as requested by the incumbent president” it’s not related to last month’s search at Mar-a-Lago. The phrase comes from a May letter from the National Archives denying Trump’s request to delay turning over documents to the FBI.

Mirati Therapeutics Inc (NASDAQ: MRTX) announced results from the KRYSTAL-1 Phase 1/2 study of adagrasib with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation. The data will be presented at the European Society for Medical Oncology (ESMO) Congress 2022. In this analysis, 44 patients received adagrasib monotherapy, and 32 received the combination of adagrasib + cetuximab, with a follow-up of 20.1 months and 17.5 months, respectively. Related: Mi

"The nasal vaccine is the best way to stop transmission or block it to the hilt,” says Dr. Eric Topol.